Bill aims to increase FDA oversight of foreign plants; Russia guides fakes destruction;

> Draft legislation would give the FDA new authority and additional manpower to increase inspections at foreign manufacturing facilities. Story

> Russia has adopted guidelines for destroying counterfeit and substandard drugs. Article

> Pall has unveiled a QA tool, the GeneDisc Rapid Microbiology System for advanced microbial quality monitoring, based on quantitative polymerase chain reaction technology. Pall release

> Specialty pharma Elite will manufacture four generics for Precision Dose. Elite release

> Tunnell Consulting has allied with Campbell Informatics, an integrated services and technology company. Tunnell release

Suggested Articles

Manufacturing

Lilly putting $400M into U.S. drug production, to add 100 jobs

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

by Eric Palmer
Manufacturing

Recipharm bolsters inhalation business with deal for U.K. CDMO

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

by Eric Palmer
Manufacturing

FDA warning letter slams Dollar Tree over its OTC drug suppliers

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

by Eric Palmer